Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Best practices in linguistic validation of clinical outcomes assessments

By Christelle Giroudet and Ana Alvarez

- PMLiVE

AbbVie’s Parkinson’s disease candidate tavapadon shows promise in phase 3 trial

More than ten million people worldwide are living with the neurodegenerative disorder

- PMLiVE

Merck shares positive phase 3 results for Keytruda/Lynparza regimen in ovarian cancer

Ovarian cancer is the seventh most common cancer in women globally

- PMLiVE

Tackling the growing burden of chronic obstructive pulmonary disease in the UK

Iona Everson from PMGroup spoke to John Forni, Country Medical Director at Sanofi UK & Ireland, about the escalating challenges of treating chronic obstructive pulmonary disease (COPD) in the UK...

- PMLiVE

Over 40 years of Ipsen in the UK: resilience and leadership in the life sciences sector

By Ioana Parsons

- PMLiVE

Eli Lilly announces $3bn expansion to US injectables manufacturing facility

The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines

- PMLiVE

NICE recommends Santhera’s Duchenne muscular dystrophy drug Agamree

Approximately 1,700 patients with the muscle-wasting disorder in England are expected to benefit from the decision

- PMLiVE

Amar Urhekar announced as CEO of Avalere Health

Global strategic partner in healthcare, Avalere Health, is proud to announce the appointment of Amar Urhekar as its new Chief Executive Officer.

- PMLiVE

A Successful Outing at ASH 2024

Medscape has wrapped up their work at this year’s ASH annual meeting in San Diego. During the conference, Medscape hosted 8 symposia that presented the latest data and supported advancing...

Medscape Education

- PMLiVE

Scientific Workshop & Consensus Paper Development: A Customer Story

Launching in a complex market? See how virtual tools can streamline consensus-building and optimize treatment planning in our latest customer story. Discover how we helped endocrinology KOLs achieve consensus on...

Impetus Digital

- PMLiVE

BOLDADVOCACY Division of BOLDSCIENCE Strengthens Leadership Team with Tori Fahrney

BOLDSCIENCE, One of the Fastest-Growing Firms in the Health Care Sector, and the Minds + Assembly Platform Reinforce Importance of Supporting Patients and Caregivers

BOLDSCIENCE

- PMLiVE

AstraZeneca’s Imfinzi granted FDA approval in limited-stage small cell lung cancer

Small cell lung cancer accounts for approximately 15% of all lung cancer diagnoses

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links